LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins
- PMID: 19497957
- DOI: 10.1152/ajpgi.90546.2008
LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins
Abstract
Liver X receptor-alpha (LXRalpha) is considered a master regulator of hepatic lipid metabolism; however, little is known about the link between LXR activation, hepatic insulin signaling, and very low-density lipoprotein (VLDL)-apolipoprotein B (apoB) assembly and secretion. Here, we examined the effect of LXRalpha activation on hepatic insulin signaling and apoB-lipoprotein production. In vivo activation of LXRalpha for 7 days using a synthetic LXR agonist, TO901317, in hamsters led to increased plasma triglyceride (TG; 3.6-fold compared with vehicle-treated controls, P = 0.006), apoB (54%, P < 0.0001), and VLDL-TG (eightfold increase compared with vehicle). As expected, LXR stimulation activated maturation of sterol response element binding protein-1c (SREBP-1c) as well as the SREBP-1c target genes steroyl CoA desaturase (SCD) and fatty acid synthase (FAS). Metabolic pulse-chase labeling experiments in primary hamster hepatocytes showed increased stability and secretion of newly synthesized apoB following LXR activation. Microsomal triglyceride transfer protein (MTP) mRNA and protein were unchanged, however, likely because of the relatively short period of treatment and long half-life of MTP mRNA. Examination of hepatic insulin-signaling molecules revealed LXR-mediated reductions in insulin receptor (IR)beta subunit mass (39%, P = 0.014) and insulin receptor substrate (IRS)-1 tyrosine phosphorylation (24%, P = 0.023), as well as increases in protein tyrosine phosphatase (PTP)1B (29%, P < 0.001) protein mass. In contrast to IRS-1, a twofold increase in IRS-2 mass (228%, P = 0.0037) and a threefold increase in IRS-2 tyrosine phosphorylation (321%, P = 0.012) were observed. In conclusion, LXR activation dysregulates hepatic insulin signaling and leads to a considerable increase in the number of circulating TG-rich VLDL-apoB particles, likely due to enhanced hepatic assembly and secretion of apoB-containing lipoproteins.
Similar articles
-
Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.Am J Physiol Gastrointest Liver Physiol. 2008 May;294(5):G1120-9. doi: 10.1152/ajpgi.00407.2007. Epub 2008 Mar 27. Am J Physiol Gastrointest Liver Physiol. 2008. PMID: 18372392
-
Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.Hepatology. 2008 Dec;48(6):1799-809. doi: 10.1002/hep.22565. Hepatology. 2008. PMID: 19026012 Free PMC article.
-
The role of LXR alpha in goose primary hepatocyte lipogenesis.Mol Cell Biochem. 2009 Feb;322(1-2):37-42. doi: 10.1007/s11010-008-9937-8. Epub 2008 Oct 31. Mol Cell Biochem. 2009. PMID: 18975056
-
Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis.Recent Pat Cardiovasc Drug Discov. 2006 Jan;1(1):21-46. doi: 10.2174/157489006775244245. Recent Pat Cardiovasc Drug Discov. 2006. PMID: 18221072 Review.
-
Liver X receptors (LXR) as therapeutic targets in dyslipidemia.Cardiovasc Ther. 2008 Winter;26(4):297-316. doi: 10.1111/j.1755-5922.2008.00062.x. Cardiovasc Ther. 2008. PMID: 19035881 Review.
Cited by
-
A Novel Mutation in LXRα Uncovers a Role for Cholesterol Sensing in Limiting Metabolic Dysfunction-Associated Steatohepatitis (MASH).bioRxiv [Preprint]. 2024 May 15:2024.05.13.593869. doi: 10.1101/2024.05.13.593869. bioRxiv. 2024. PMID: 38798597 Free PMC article. Preprint.
-
Liver X receptors and liver physiology.Biochim Biophys Acta Mol Basis Dis. 2021 Jun 1;1867(6):166121. doi: 10.1016/j.bbadis.2021.166121. Epub 2021 Mar 11. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 33713792 Free PMC article. Review.
-
Chemical genetic-based phenotypic screen reveals novel regulators of gluconeogenesis in human primary hepatocytes.NPJ Genom Med. 2018 Aug 15;3:20. doi: 10.1038/s41525-018-0062-7. eCollection 2018. NPJ Genom Med. 2018. PMID: 30131871 Free PMC article.
-
Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.Oxid Med Cell Longev. 2018 May 31;2018:2548154. doi: 10.1155/2018/2548154. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29955245 Free PMC article. Review.
-
Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis.Lipids Health Dis. 2017 Sep 6;16(1):166. doi: 10.1186/s12944-017-0558-7. Lipids Health Dis. 2017. PMID: 28874158 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous